Elizabeth Charlotte Moser M.D., Mba

Elizabeth Charlotte Moser MD PhD MBA has a broad and extensive work experience in the healthcare and biosciences industry. Elizabeth Charlotte has held key leadership roles such as Chief Scientific Officer, Chief Medical Officer, Senior Business Consultant, Head of Clinical Development, and Senior Advisor in various companies including Nanocan Therapeutics Corporation, Deka Biosciences, Galera Therapeutics, and DeepLook Medical. Elizabeth Charlotte'sexpertise lies in clinical development, research, and strategic leadership within the industry.

Elizabeth Charlotte Moser obtained their Doctor of Medicine (MD) degree from Vrije Universiteit Amsterdam (VU Amsterdam) in 1998. Elizabeth Charlotte then pursued a Doctor of Philosophy (PhD) degree in Oncology and Cancer Biology from Leiden University from 2002 to 2007. Moser also completed a Radiation Oncology Residency Program at Leiden University from 2000 to 2006. In 2015, they earned a Master of Business Administration (MBA) from MIT Sloan School of Management. Additionally, Moser obtained a certificate in drug development from Harvard Medical School and completed a program in AI in business strategy at Massachusetts Institute of Technology in 2018. Elizabeth Charlotte later pursued a program in drug and medical device development at MIT xPRO in 2023. In 2019, Moser became a Member of the Association of Clinical Research Professionals.